|
Volumn 76, Issue 1, 2001, Pages 32-37
|
Pharmacokinetics of testosterone after percutaneous gel or buccal administration
|
Author keywords
Postmenopausal testosterone replacement; Testosterone lozenge; Transdermal testosterone gel
|
Indexed keywords
ANDROSTANEDIOL;
ANDROSTANOLONE;
GLUCURONIDE;
TESTOSTERONE;
TESTOSTERONE PROPIONATE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESTROGEN THERAPY;
FEMALE;
GEL;
HUMAN;
LOZENGE;
OVARIECTOMY;
PRIORITY JOURNAL;
RADIOIMMUNOASSAY;
RANDOMIZED CONTROLLED TRIAL;
TESTOSTERONE BLOOD LEVEL;
ABSORPTION;
ADMINISTRATION, CUTANEOUS;
ADMINISTRATION, ORAL;
ANDROSTANE-3,17-DIOL;
CHEEK;
DIHYDROTESTOSTERONE;
FEMALE;
GELS;
HUMANS;
MIDDLE AGED;
OVARIECTOMY;
PILOT PROJECTS;
TESTOSTERONE;
TIME FACTORS;
|
EID: 0034955444
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(01)01827-1 Document Type: Article |
Times cited : (37)
|
References (20)
|